IGF-1 LR3 Dosing & Reconstitution Guide
Dosing Protocol
Route: Subcutaneous or Intramuscular Frequency: Once daily Dose Range: 20-100 mcg/day; research protocols commonly use 50-80 mcg/day Cycle Length: 4-6 weeks; off-cycle recommended to prevent receptor downregulation Timing: Post-workout or morning; monitor blood glucose
Reconstitution
Vial Size: 1mg Water Volume: 1mL Concentration: 1mg/mL
Storage
Lyophilized: -20 °C (-4 °F) Reconstituted: 2-8 °C (35.6-46.4 °F) Shelf Life: 21 days
Injection Sites
Abdomen, Target muscle (IM for localized effect), Thigh
Safety & Contraindications
Safety: Hypoglycemia risk — IGF-1 has insulin-like glucose-lowering effects Potential organ enlargement with chronic use (intestinal growth observed in animals) Joint pain, water retention, carpal tunnel-like symptoms (GH/IGF axis effects)
Contraindications: Active cancer or history of cancer (IGF-1 promotes cell proliferation); Diabetes or hypoglycemia disorders; Pregnancy and breastfeeding